[Semiological criteria for the use of drug therapy in neuropsychiatry].
D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D001523:Mental Disorders / Q000188:drug therapy*; D008728:Methotrimeprazine / Q000627:therapeutic use*; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use*; D014291:Trimeprazine / Q000627:therapeutic use*
D000697:Central Nervous System Stimulants; D006993:Hypnotics and Sedatives; D014291:Trimeprazine; D008728:Methotrimeprazine; D002746:Chlorpromazine
Les critères séméiologiques de l'application des thérapeutiques pharmacologiques en neuro-psychiatrie.